Dr Kent C Difiore, MD | |
3838 S 700 E, Suite 100, Salt Lake City, UT 84106-1466 | |
(801) 269-0231 | |
(801) 269-0304 |
Full Name | Dr Kent C Difiore |
---|---|
Gender | Male |
Speciality | Internal Medicine - Hematology & Oncology |
Location | 3838 S 700 E, Salt Lake City, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649229618 | NPI | - | NPPES |
107006480101 | Other | UT | SELECT HEALTH |
05485 | Medicaid | UT | |
830002643 | Other | UT | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 160097-1205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kent C Difiore, MD 1121 E 3900 S, Suite C-240, Salt Lake City, UT 84124-1214 Ph: (801) 266-0878 | Dr Kent C Difiore, MD 3838 S 700 E, Suite 100, Salt Lake City, UT 84106-1466 Ph: (801) 269-0231 |
News Archive
Babies and asymptomatic cases account for up to half of COVID-19 infections in the under-five age group, which has implications for vaccination programs, a new UNSW study has found.
New research from Western University has shown that both women and men are significantly more likely to have a heart attack or another major cardiovascular event within thirty days of having a stroke.
In a study that included approximately 95,000 children with older siblings, receipt of the measles-mumps-rubella (MMR) vaccine was not associated with an increased risk of autism spectrum disorders (ASD), regardless of whether older siblings had ASD, findings that indicate no harmful association between receipt of MMR vaccine and ASD even among children already at higher risk for ASD, according to a study in the April 21 issue of JAMA, a theme issue on child health.
"Now is not the time for the United States - or any other country - to reduce spending on programs that deliver life-saving drugs at so tiny a cost," a Des Moines Register editorial states, noting the relatively small cost of PEPFAR.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of a patent listed by Genzyme Corporation in connection with RENVELA® (sevelamer carbonate for suspension), 2.4 g and 0.8 g.
› Verified 6 days ago
Dr. Mehmet Akkaya, M.D Hematology & Oncology Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689 | |
Dr. Willard Dere, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Megan Meier, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Joel Money, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mchale O. Anderson, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451 | |
Siddharth K. Iyengar, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Taryn A. Young, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398 |